BP2-10485-95929
2 vaccinations
8 coded responses
11 check-ins
8 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 926 / CA
- Registered
- 2021-05-23
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-05-22
Dose 1 — Pfizer-BioNTech
-
2021-05-23
Registered in v-safe
-
2021-05-23
Survey response — days 1–6 daily, dose 1MedDRA: Taste disorder, Tongue exfoliation, Trigeminal nerve disorder — Feeling: Fair · Site: Pain · Headache, Rash, not including the immediate area around the injection siteFree text: White Peeling tongue and altered sense of taste, trigeminal nerve painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-24
Survey response — days 1–6 daily, dose 1MedDRA: Glossitis, Tongue coated — Feeling: Fair · Site: Pain · Muscle or body achesFree text: Glossitis and white patchy tongueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-25
Survey response — days 1–6 daily, dose 1MedDRA: Glossitis, Odynophagia, Tongue coated, Tongue erythema, Tongue exfoliation — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Glossitis and tongue peeling, white and red, pain swallowingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-06-02
Health check-in — day 7, dose 1Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-06-05
Survey response — day 14, dose 1MedDRA: Autoimmune disorder, Fatigue, Lymphadenopathy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Extra fatigue and some lymph swelling, began after the vaccine. Also autoimmune symptoms are worse but manageable.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-05
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-12
Dose 2 — Pfizer-BioNTech
-
2021-06-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-06-15
Survey response — days 1–6 daily, dose 2MedDRA: Swelling, Tongue disorder — Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Tongue peeling and swollen tastebuds/ familiar immune response to vaccines and infectionsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-10
Survey response — day 28, dose 2MedDRA: Fatigue, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Autoimmune flare, fatigue, new onset nerve symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-10
Report sent to call center — day 28, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-19
- 2021-07-21
-
2021-09-13
Survey response — 3 months, dose 2MedDRA: Muscular weakness, Neuralgia, Pre-existing disease, Systemic lupus erythematosus — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Increased nerve pain and muscle weakness associated with nerves, continuing lupus flare which began showing up a little less than a week after the second vaccineMedDRA releases: 2024-11 · check-in free text available
-
2021-09-13
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-14
-
2022-06-12
Survey response — 12 months, dose 2MedDRA: Diaphragm muscle weakness, Facial spasm, Hemiparesis, Muscular weakness, Physiotherapy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Progressive Neuromuscular weakness on right side of body. Hemifacial spasms and hemidiaphragmatic weakness, after third shot. Seemed to set in motion a deeper disease process. · Healthcare visit (other): Physical therapyMedDRA releases: 2024-11 · check-in free text available
-
2022-06-12
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-13
-
2022-06-15
Callback requested for02:00PM ET
-
2022-06-15
Call successfulDoes not wish to fill out VAERS report
-
2022-06-15
Call successfulDoes not wish to fill out VAERS report
-
2022-06-15
Call successfulDoes not wish to fill out VAERS report
-
2022-06-15
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-22 | Pfizer-BioNTech | |
| 2 | 2021-06-12 | Pfizer-BioNTech |
Call center
4 call center cases
4 successful
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): White Peeling tongue and altered sense of taste, trigeminal nerve pain
Systemic reaction (other): Glossitis and white patchy tongue
Systemic reaction (other): Glossitis and tongue peeling, white and red, pain swallowing
Release 8 — day 14, dose 1
Symptoms: Extra fatigue and some lymph swelling, began after the vaccine. Also autoimmune symptoms are worse but manageable.
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Tongue peeling and swollen tastebuds/ familiar immune response to vaccines and infections
Release 9 — day 28, dose 2
Symptoms: Autoimmune flare, fatigue, new onset nerve symptoms
Release 9 — 3 months, dose 2
Symptoms: Increased nerve pain and muscle weakness associated with nerves, continuing lupus flare which began showing up a little less than a week after the second vaccine
Release 12 — 12 months, dose 2
Symptoms: Progressive Neuromuscular weakness on right side of body. Hemifacial spasms and hemidiaphragmatic weakness, after third shot. Seemed to set in motion a deeper disease process.
Healthcare visit (other): Physical therapy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Physiotherapy | · | · | ✓ |
| SD | Autoimmune disorder | ✓ | ✓ | ✓ |
| SD | Diaphragm muscle weakness | · | · | ✓ |
| SD | Facial spasm | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hemiparesis | · | · | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Neuralgia | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Systemic lupus erythematosus | · | · | ✓ |
| SRO | Glossitis | ✓ | ✓ | ✓ |
| SRO | Odynophagia | ✓ | ✓ | ✓ |
| SRO | Swelling | ✓ | ✓ | ✓ |
| SRO | Taste disorder | ✓ | ✓ | ✓ |
| SRO | Tongue coated | ✓ | ✓ | ✓ |
| SRO | Tongue disorder | ✓ | ✓ | ✓ |
| SRO | Tongue erythema | ✓ | ✓ | ✓ |
| SRO | Tongue exfoliation | ✓ | ✓ | ✓ |
| SRO | Trigeminal nerve disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release